ARCHIVES

DCT Board Approves Continuing Neutron Trials Pas 1989 Expiration, With New Funding Plan

This article is from The Cancer Letter archive.

Vol. 14 No. 24 | June 10, 1988

Download PDF Visit The Full Archive

Related Articles

In Sign-Off Of Two Orphan Drugs, ODAC Leaves Efficacy Interpretation To Docs

November 27, 1998

Includes Sept. Business & Regulatory Report.

September 26, 2003

In Brief: John Tamps New ACR President; Stanley Order ASTRO President Elect; Cairoli Heads Training

December 11, 1987

The Clinical Cancer Letter To End Print Edition In 2010

November 27, 2009

MD Anderson Expands Reach Into Florida, Ohio

September 26, 2014

Block, Committee Agree; No New PDQ For General Public

January 11, 1985